Zantac (Ranitidine) & Duration of Use

Basic Details
Last Updated
Tuesday, September 15, 2020
Health Outcome(s)
duration of use
Drug Use
Regulatory Determination / Use

This analysis provided information on use patterns of prescription ranitidine in patients with Medicare and private health care insurance. These data, in addition to data from other sources, were used to provide context for CDER’s Nitrosamine Impurities Task Force to better understand the use patterns among U.S. individuals. These data also informed the feasibility of a Sentinel analysis to evaluate clinical outcomes associated with prescription ranitidine use.